Ladenburg Thalmann Financial Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
BG
AG
RWA
Ladenburg Thalmann Financial Services's MRNA Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services increased its Moderna (MRNA) stake by 106% in Q4 2019, buying an estimated $14.2K and bringing the position to 1,562 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.
Ladenburg Thalmann Financial Services first reported a position in MRNA in Q4 2018 and has held it in 5 quarters since. 159 funds tracked by Wall St. Rank hold MRNA as of Q4 2019.
- Ladenburg Thalmann Financial Services held 1,562 shares of Moderna worth $31K as of Q4 2019.
- Ladenburg Thalmann Financial Services bought 802 Moderna shares in Q4 2019, an estimated $14.2K.
- Moderna made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3859 holding.
- Ladenburg Thalmann Financial Services first reported a position in Moderna in Q4 2018 and has held it in 5 quarters since.
- 159 funds tracked by Wall St. Rank held Moderna as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.